Buy FOXO4-DRI Online

FOXO4-DRI Peptide – Research Information, Uses & Specifications

Specifically, FOXO4-DRI is a synthetic peptide with Seno lytic properties, targeting and eliminating senescent cells.

However, Dr. Peter de Keizer’s team at Erasmus MC showed FOXO4-DRI reversing aging signs in mice.

How FOXO4-DRI Peptide Works

Moreover, FOXO4-DRI disrupts the interaction between FOXO4 and p53, a key regulator of cell cycle and apoptosis.

Specifically, in senescent cells, FOXO4 binds to p53 to prevent these damaged cells from dying.

As a result, the DRI peptide mimics FOXO4 and frees p53 to trigger apoptosis in senescent cells.

Thus, this selective removal helps clear out aged or dysfunctional cells without harming healthy ones.

Potential Benefits of FOXO4-DRI

1. Cellular Rejuvenation
   Eliminating senescent cells can promote the regeneration of healthy tissue and improve cell function.

2. Anti-Aging Effects
   In mouse studies, FOXO4-DRI reversed signs of aging such as hair loss, kidney dysfunction, and reduced activity levels.

3. Improved Organ Function
   By reducing inflammation and cellular waste, it may improve function in organs such as the liver, kidneys, and heart.

4. Cognitive Support
   Clearing senescent cells in the brain could potentially support memory and cognitive health.

5. Increased Lifespan and Healthspan
   In preclinical models, FOXO4-DRI extended health span and showed promise in extending lifespan.

Current Status and Research

Human Trials: As of now, FOXO4-DRI has not undergone formal clinical trials in humans. Its use is considered experimental, and it is not FDA-approved.

Availability: It is sometimes sold by research chemical suppliers, but quality and safety are not guaranteed for human use.

Legal and Ethical Considerations: Because it is not approved for therapeutic use, self-experimentation carries risks and should be approached with caution.

Risks and Considerations

Unknown Long-Term Effects

Off-Target Cell Death

Immune System Reactions

Quality Control in Unregulated Sources

Conclusion

FOXO4-DRI represents an exciting development in senolytic therapy and anti-aging science, with strong preclinical results in clearing senescent cells and potentially reversing age-related decline.

However, due to the lack of human trials, its safety and effectiveness remain unproven in people.

Those interested in FOXO4-DRI should follow ongoing research and consult medical professionals before considering its use.